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ABSTRACT
The inhibitor sensitivities and kinetic studies support
that tryptamine and dopamine are common substrates for MAO,
and 5-HT and benzylamine are specific substrates for MAO A
and MAO B respectively in the whole forebrain, brain stem,
cerebellum and liver of rat. Moreover, clorgyline and
deprenyl are proved to be highly specific inhibitors for
MAO A and MAO B respectively. Results from the kinetic
studies of inhibitors towards tryptamine, 5-HT and berzyl-
amine indicate that more than two binding sites are localized
on MAO molecule(s). Thermal denaturation studies showed
that MAO B was more susceptible to heat inactivation than
MAO A. The above findings suggest that the microenvironments
of these two types of enzymes may be different. The char-
acteristics of the MAO in the cerebellum differs much from
those of the whole forebrain and brain stem, but is similar
to certain extent to those in, the liver. These differences
may be due to the different functional roles of these
structures.
The developmental time-tables of multiple forms of
MAO activity are different, and a caudal to rostral sequence
of development was observed in the structures studied.
MAO A was found to be relatively more active in the early
period in the postnatal life whereas MAO B is relatively
more active in the later period. The developmental changes
in A/B ratios and kinetic parameters of MAO in the structures
studied indicate that changes in microenviroment of the
enzyme binding sites may occur during development. Also
these changes may be geared to meet the physiological roles
of MAO in these structures.
Methadone, but not morphine, affected MAO activities
in vitro,while both opiates failed to alter brain MAO
activities after short term administration and only the
benzylamine-metabolizing activity was affected by long
terns methadone treatment. Also, both opiates had only
minimal effect on the development of MAO in the offspring
born to drug-treated mothers. These findings suggest that
these two opiates do not affect MAO activities, in vitro,
through a common mechanism and that these opiates can be
metabolized rapidly in vivo.
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1CHAPTER I: GENERAL INTRODUCTION
1.1 Introduction
The central nervous system (CNS) is the master of the
body, yet its biochemistry and physiology are still not
well understood. Over the last ten years, more and more
attentions have been focused on the biochemistry of the
brain. Some major aspects of neurochemistry currently
under investigation are the effects of drugs on the CNS,
neurotransmitter metabolism and interactions, neuropsy-
chiatric and neurological disorders. The fruit of these
studies has broadened our knowledge of the neurochemical
basis of Parkinson's disease and its therapy (Hornykiewicz,
1972; Knoll, 1978a; Lloyd et al., 1975); and of the relation-
ship between the etiology of schizophrenia and catecholamine
metabolism (Carlsson, 1975). Another stream of neurochemistry
that has also drawn much interest recently is the study
of the biochemistry of brain development. Influenced by
the unfortunate thalidomide tragedy of the early 1960's
(McBride, 1961), much interests have been directed to
study the effects of drugs on brain development. It is
believed that research in these fields may contribute
not--,only to the treatment of brain disorders, but also
provide another approach to know more about the normal
function of the brain.
21.2 Develonment of the Brain
The growth patterns as seen in the emergence of brain
function vary among species. Investigators found very
little muscular coordination and no rhythmic electrical
activity in the brain of newborn rats. On the other hand,
the newborn guinea pig is self-sufficient at birth and
responds to a variety of stimuli, as evidenced by complex
rhythmic electrical activity in the brain. The develop-
ment of the newborn human infant is somewhat intermediate
between that of the newborn rat and the guinea pig.
Mcllwain (1959) categorized the development of brain,
based on the morphology, function, and chemical composition,
in the following stages:
Stage I. Cell Proliferation and Differentiation.
Functionally, no nerve impulses are transmitted in the
brain during this period, which lasts until the birth of
the rat or approximately three-quarters of gestation in
the guinea pig and man. At the end of this period the
number of brain cells almost reaches adult values.
Stage II. Cell Growth and Differentiation. In this
period, there is an increase in size of the brain cells
and outgrowth of axons in dendritic connections. In the
rat, this stage extends to 10 days after birth and in man
it lasts until birth.
Stage III. Rapid Myelination. In this phase, the
overall growth of the brain decreases but there is very
rapid formation of myelin. This represents the period
from the twelfth day to twenty-fifth day after birth in
3the rat, from 46 days gestation to birth in guinea pig,
and from birth to 120 days of age in man.
Stage IV. Maturation. During this stage, myelination
is complete and the brain attains its full morphological
and functional maturity.
Fluorescence histochemical and autoradiographic tech-
niques (Olson et al., 1973; Rappoport et al., 1971), and
single cell recording and iontophoretic studies in intact
neurons (Lanier et al., 1976) have shown that the cells
of the brain do not develop simultaneously but rather,
each region has its own developmental time-table. In
general, there appears to be a caudal to rostral sequence
of development of the neurotransmitter systems, e.g. the
noradrenergic and serotonergic systems, with the caudal
regions (midbrain and brain stem) reaching maturity prior
to the more rostral areas (cerebral cortex and striatum
etc.) (Pscheidt and Himwich, 1966 Lanier et al., 1976).
The enzymes with special functional importance in
the CNS have also been studied detailly (for review see
Seiler, 1969). These studies revealed that in the early
stages of development the enzymes responsible for the
formation of structural components of the proteins, lipids,
and nucleic acids, and enzyme systems that are connected
with the mechanism of growth are predominant first.
These are followed by the enzymes responsible for cell
differentiation, such as acid %nd alkaline phosphatases
which play a part in the differentiation of neurons and
glia, while enzymes responsibl: for the final function
4of the brain appear later, for examples, tyrosine hydro-
xylase (TH), and monoamine oxidase (MAO), which participate
in the transmission of impulses. Thus the appearance of
these enzymes have been used as an index to reflect
functional maturity of the brain.
Many authors in the past 30 years have studied the
development of MAO in the brain due to its physiological
importance in brain function and dysfunction (for review
see Gripois, 1975). However, the results from different
authors are generally impossible to be compared because
of the multiplicity of the assay procedures used (Achee
and Gabay, 1977a; Jain et al., 1973). Furthermore, dis-
crepancies existed among the results reported by various
authors due to different sample preparations used (Achee
and Gabay, 1977a), different regions of the brain studied
(Achee and Gabay, 1977a Bourgoin et al., 1977; Harada et
al., 1975), and/or differences in strain of animals inves-
tigated (Youdim et al., 1975). Thus, no conclusive picture
can be drawn on the development of MAO from these studies.
1.3 Neurotransmitters and Synaptic Transmission
The function of the brain is mainly achieved by the
transmission of signals from one neuron to another (or
from neurons to neurons). In the mammalian CNS, the trans-
mission of messages is achieved mainly by biochemical
processes. To accomplish the task of transmitting, modula-
ting and integrating many different neuronal messages at
the same time, the brain utilizes an elaborate code system.
The mammalian CNS makes use of a much larger variety
5of neurotransmitters than the peripheral nervous system.
This is not surprising in view of its highly complex function.
So far, many central neurotransmitter candidates have
been identified (for review see Mulder and Snyder, 1976),
the more or less well-accepted ones are: acetylcholine
catecholamines, and 5-hydroxytryptamine (5-HT).
1.4 The Metabolism of Monoamines in the Brain
The monoamines, noradrenaline (NA), dopamine (DA)
and 5-HT have been the subject of extensive investigations,
because of their important role in the regulation of mood
and behavior. (Anden et al., 1969; Axelrod, 1965; Axelsson
1971; Molinoff and Axelrod, 1971; Chase and Murphy, 1973).
Also, derangement of these monoamines plays an important
role in the physiopathology of brain disorders, such. as
Parkinson's disease (for review see Hornykiewicz, 1972)
and schizophrenia (Carlsson, 1975).
The enzymes involved in monoamine biosynthesis are
mainly localized in nerve terminals (Nagatsu et al., 1971
Coyle, 1972; Coyle and Kuhar, 1974). The catecholamines
are synthesized from the circulating dietary amino acid
L-tyrosine, which after taken up by the brain is first
converted to L-Dopa by the enzyme tyrosine hydroxylase
(TH). An L-aromatic amino acid decarboxylase transforms
L-Dopa to dopamine, which is the final reaction step in
dopaminergic neurons. In noradrenergic neurons dopamine
is hydroxylated to form noradrenaline by dopamine- B-hydro-
xylase (DBH). The first step in noradrenaline biosynthesis
occurs in the nerve ending cytoplasm and the final step
6in the synaptic vesicles (Mulder and Snyder, 1976). Both
NA and DA are known to inhibit TH activity through which the
biosynthesis of these amines are regulated. (Udenfriend
et al.., 1965).
Serotonin (5-HT), an indoleamine is synthesized from
the dietary amino acid L-tryptophan, which after taken up
by the brain is first converted to 5-hydroxytryptophan
(5-HTP) by tryptophan hydroxylase, then decarboxylated by
L-aromatic amino acid decarboxylase to produce 5-HT.
After being released from the nerve endings, monoamines
are taken up into the nerve terminals by high-affinity re-
uptake systems. These re-uptake systems are rapid, efficient
and are energy-requiring. They serve as the processes to
terminate monoaminergic neurotransmission.
As soon as monoamine molecules have been taken up in-
side the terminal, they will be partly inactivated by MAO
and partly captured by the storage vesicles.
Monoamine oxidase converts monoamines to their corres-
ponding aldehydes. These aldehyde intermediates are rapidly
metabolized either by oxidation by aldehyde dehydrogenase
to the corresponding acid or by reduction by aldehyde reductase
to the corresponding alcohol or glycol.
In the CNS, the primary metabolites of dopamine found
are homovanillic acid and dihydroxyphenylacetic acid and
a small amount of 3-methoxytyramine. On the other hand,
the major metabolite of noradrenaline found in the brain is
the glycol derivative, 3-methoxy-4-hydroxyphenethylene-
gl ycol (MHPG). The aldehyde intermediate of 5-HT, 5-hydroxy-
indoleacetaldehyde, is further oxidized to 5-hydroxyindole-
7acetic acid (5-HIAA).
1.5 Monoamine Oxidase (MAO)
The enzyme monoamine oxidase (monoamine: oxygen oxido-
reductase (deaminating), EC 1.4.3.4) catalyses the oxidative
deamination of a wide variety of amines to produce the
corresponding aldehvdes_
Monoamine oxidase (MAO) is a particle-bound protein,
localized mainly in the outer membrane of mitochondria,
although a partial microsomal localization cannot be ex-
cluded. There is some evidence for a riboflavin-like
material in MAO (Tipton, 1973). MAO is usually considered
to be an intraneuronal enzyme, but it occurs in abundance
extraneuronally. However, it is the intraneuronal enzyme
that seems to be important in monoamine metabolism (Tipton,
1973).
Two types of MAO have been identified in homogenates
of human and rat brain, and also in the rat liver, by their
sensitivity to inhibitors and their specificity for sub-
strates (Johnston, 1968). Moreover, MAO can be differ-
entiated by their thermostability (Squires, 1968; Yang
et al., 1972) and their sensitivity to trypsin digestion
(Yang et al., 1972). By the terminology of Johnston (1968),
type A MAO is sensitive to the inhibitor clorgyline, and
noradrenaline (Goridis and Neff, 1971) and 5-HT (Johnston,
1968) appear to be the preferred substrates for this enzyme.
In contrast, type B enzyme is sensitive to the inhibitor
deprenyl (Knoll and M: gyar, 1972), and benzylarnine (Hall
et al., 1969) and B-ph nylethylamine (Yang and Neff, 1973)
8appear to be the preferred substrates. Dopamine (Yang
and Neff, 1974), tyramine and tryptamine (Johnston, 1968)
are the common substrates for both forms of enzymes.
The characteristics of two types of MAO in rat brain and
liver were shown in Table 1.1.
Multiplicity of MAO has also been demonstrated by
electrophoretic techniques. Polyacrylamide gel electro-
phoresis of solubiliZed and highly purified MAO produces
4- 5 active bands with different substrate and inhibitor
specificities (Collins et al., 1970 Youdim et al., 1969,
1970). However, Houslay and Tipton (1973) found that treat-
ment of solubilized preparations of MAO from rat liver
with chaotropic agents, such as sodium perchlorate, resulted
in the abolition of the electrophoretic multiplicity without
loss in activity towards any of a range of substrates.
Chaotropic agents are known to be capable of freeing pro-
teins from association with lipid material by weakening
hydrophobic bonds and a considerable amount of lipid material
could be separated from the enzyme after treatment with
the chaotropic agent. Moreover, this treatment also resulted
in the abolition of different thermal stabilities of the
enzyme activity towards different substrates and of the
selective effects of clorgyline (Houslay and Tipton, 1973).
Also, the importance of lipid in MAO activity was shown
by Oreland and Ekstedt (1972) who demonstrated that binding
of lipid to purified pig liver MAO results in a considerable
increase in thermal stability. These and other studies
suggest that multiple forms of MAO may represent a single
9Table 1.1 Some characteristics of monoamine


















enzyme species to which either different amounts or types
of phospholipid membranous material are attached (Houslay
and Tipton, 1973, 1974 Youdim and Collins, 1975). This
hypothesis has been supported by recent immunological
studies on human and rat liver MAO (Dennick and Mayer,
1977). These authors observed that the MAO activities,
assayed with tyramine, 5-HT and benzylamine, were completely
immunoprecipitated by the same volume of antiserum.
It has been proposed that the active site of MAO
has both a hydrophobic and a polar region that participate
to varying degrees in binding of different amines. In
binding of substrate without a p-hydroxyl group to both
the A and B form of the enzyme only the hydrophobic region
of the active site may be involved. On the other hand,
in the binding of substrates with a p-hydroxyl group to
the 13 form of the enzyme repulsive force may act on the
p-hydroxyl group, while these forces may not be present
when these substrates bind to the A form of the enzyme
(Severina, 1973).Knoll (1978b) further suggested that
these two types of MAO discriminate between the 5-hydroxy-
indole ring and the benzene ring, i.e. the hydrophobic
regions in type A enzyme and type B enzyme are more suit-
able for binding indole and benzene group, respectively.
Moreover, the binding of substrate is also determined
by the optimum length and the structure of the alkyl chain
between the indole or benzene group and the nitrogen moiety,
and the attachment of the nitrogen to the enzyme in the
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vicinity of the covalently bound flavin. According to this
hypothesis, 5-HT and B-phenylethylaniine should have the
lowest Km for MAO A and MAO B respectively.
However, the results of mixed substrate experiments
of White and Wu (1975) showed that B-phenylethylamine
appears to be metabolized at enzyme active sites independent
from those which bind 5-HT, and noradrenaline competes
with 5-HT for an enzyme site, but also may be catalysed at
an additional site which is independent of 5-HT binding.
These findings suggest that more than two binding sites
are located on MAO molecule(s).
The profound effects of the lipid environment on the
properties of MAO indicate that it will be necessary to
study the enzyme in its membrane-bound form rather than
in soluble preparations if the results are to have any
direct relevance to the situation within the cell. There-
fore, most investigations of the multiplicity of MAO have
been focused on the multiple forms (i.e. MAO A and MAO B)
designated by Johnston (1968) rather than those separated
by PA gel electrophoresis.
1.6 Physiological Roles of MAO
The role and relative importance of the two types
of MAO in physiological and pathological states is currently
unclear. However, several physiological roles of MAO
have been postulated. In neural tissues the function
of the presynaptically localized MAO may be to metabolize
released transmitter amines after re-uptake into the nerve
endings or after leaking from the intraneuronal storage
12
vesicles. Under conditions in which mAO is inhibited,
the capacity of the nerve endings to take up amines becomes
exhausted as the storage vesicles become saturated and
the level of free intraneuronal amine rises (Trendelen-
burg et al., 1972). These authors suggested that the
re-uptake process itself seems to be dependent on the
presence of MAO in the nerve terminal because it appears to
be governed by the relative concentrations of free neuronal
and extraneuronal amines.
Since both NA and DA are known to inhibit tyrosine
hydroxylase activity (Udenfriend et al.,1965) and that
both amines are susceptible to deamination by MAO, it
has been postulated that MAO may serve to regulate end-
product feedback inhibition on tyrosine hydroxylase,
thereby regulates both the rate and amount of neurotrans-
mitter synthesis for optimal neuronal function. MAO may
further limit NA synthesis by curtailing the intraneuronal
concentration of DA, the immediate precursor of NA
biosynthesis (Clarke and Sampath, 1973).
In addition to the brain, MAO also occurs in great
abundance in the liver. The high MAO activities of this
tissue probably constitute a very important detoxication
barrier, which normally prevents a variety of pharmaco-
logically active amines absorbed from the intestine from
gaining access to the general circulation. The liver
enzyme also plays an important role in the metabolism of
catecholamines (particularly adrenaline) released into the
circulation from the adrenal medulla.
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1.7 Effects of Opiates on Brain Functions
The administration of a single dose of morphine or
other narcotic drugs leads to a spectrum of pharmacological
responds including depressant effects: a decrease in res-
piratory rate, blood pressure, awareness of pain, gastro-
intestinal motility, anxiety, etc., and stimulant effects:
euphoria and convulsions. Clinical studies showed that
babies born to addicted mothers exhibit the so called
"neonatal withdrawal symptoms", which are characterized by
unusually strong reflex responses, tremor, irritability,
excessive and high-pitched crying, disturbed sleep, and a
voracious appetite accompanied by failure to gain weight.
Later, the children tend to be hyperactive and have short
attention spans(Kolata, 1978).
Animal studies have also shown that the administration
of opiates to pregnant animals may affect both functional
and morphological development of offspring (Friedley, 1978
Tuchmann-Duplessis, 1977). Offspring maternally subjected to
mathadone (Zagon and McLaughlin, 1977) or morphine addiction
(Friedler, 1978) have been shown to have abnormal body growth,
abnormal brain development (Zagon and McLaughlin, 1977,1978),
and abnormal opiate receptor development (Tsang and Ng, 1980).
Overwhelming evidence from physiological and biochemical
studies indicates that most of the responses to the adminis-
tration of opiates are reaction of the central nervous
system (for review see Clouet, 1971). There have been many
studies on central neurotransmitter alteration during acute,
chronic, and withdrawal stages of opiate administration,
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however, the effects of the drug on neurotransmitter function
are still unclear (for review see Clouet and Iwatsubo,
1975; Erickson, 1978).
Since a great deal of evidence suggested that catechol-
amines (Clouet and Ratner, 1970; Smith et al., 1970) and
5-HT (Haubrich and Blake, 1973) may mediate the effects
of opiates on the function of the CNS (for review see
Clouet and Iwatsubo, 1975), and that MAO plays a signifi-
cant role in regulating the concentrations of monoamines
in the brain, several workers have investigated the effects
of opiates on this enzyme (Catravas et al., 1977; Reis
et l., 1970). However, the results of these workers are
contradictory, and very few workers have studied the effects
of opiates on multiple forms of MAO in the brain. Moreover,
the effect of antenatal exposure to opiates on the develop-
ment of multiple forms of MAO in the brain have even not
been investigated.
1.8 The Scope of Present Studv
In view of the physiological and pharmacological import-
ance of monoamine oxidase in the brain and liver, and the
social concerns to drug addiction in this society, the
present study was carried out to investigate:
1. The nature of multiple forms of MAO in rat brain and
liver;
2. The changes of multiple forms of IIAO in rat brain and
liver during develoment;
3. The regional differences of multiple forms of MAO
15
in adult and in develotiinr ratan
4. The effects of opiates on multiple forms of MAO in
rat brain and liver; and
5. The effects of antenatal exposure to opiates on the
development of multiple forms of MAO in rat brain and
liver.
The rat was chosen because the development of amines
biosynthesis takes place almost entirely postnatally (Mabry
and Campbell, 1977) and because the brain is of sufficient
size even at young ages to permit reliable dissection
and analysis. Whole forebrain, brain stem and cerebellum
were selected in the present study because the effect of
opiates on catecholamine synthesis in these areas have
been studied (Clouet and Ratner, 1970; Smith et al., 1972),
thus the effect of opiates on amine biosynthesis and MAO
activity can be compared.
Since MAO also occurs in great abundance in the liver
which acts as a very important detoxication barrier for
a variety of pharmacologically active amines, and that
the liver is the main site for opiates metabolism (for
review see Goodman and Gilman, 1975), the effects of opiates
on the activity of MAO in rat liver were also investigated.
16






obtained from New England Nuclear Corporation, Boston.
Tryptamine hydrochloride, 5-hydroxytryptamine creatine
sulfate complex and dopamine hydrochloride were purchased
from Sigma while benzylamine was obtained from The British
Drug Houses Ltd. (BDH), England.
The extraction solvents: toluene, ethyl acetate,
tetrahydrofuran and cyclohexane were obtained from Ajax
Chemicals, Merck Co., Mallinckrodt Chemical Works and
BDH, respectively.
Morphine HCl and methadone were purchased from BDH.
Clorgyline
propylaminej was generously supplied by May and Baker Ltd.,
England, and Deprenyl, - - phenylisopropylmethylpropinyl-
amine) was a generous gift from Dr. J. Knoll, Semmelweis
University of Medicine, Budapest, Hungary.
2,5-diphenyloxazole (PPO) was purchased from Sigma,
1,4-di-2-(5-phenyloxazolyl)-benzene (POPOP) was bought
from BDH.
All other chemicals used were of analytical grade.
N-Methyl-N-propargyl-3-(2.4-dichlorophenoxyl
Side Chain-2-14c 51.5 mCi/mmol
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2.2 Methods
2.2.1 Administration of Opiates
Sprague-Dawley rats inbred in our laboratory
were used in these studies. Animals were kept in
a temperature-controlled room with alternating periods
of 12-hours light and 12-hours darkness.
In the investigation of opiate effects on the
developmental patterns of MAO, female rats with body
weight about 250 g were injected twice daily with
morphine (5 mg/Kg, i.p.), or methadone (5 mg/Kg, i.p.),
or same volume of vehicle (saline). After three days
of drug treatment with morphine or methadone, two
drug-treated females were caged with one drug-naive
male and allowed to mate. Administration of opiates
were maintained throughout pregnancies. At one week
before expected parturition, females were caged separ-
ately. Births were recorded within 12 hours of partu-
rition and the litter sizes noted.
To investigate the effects of opiates on MAO
activity in adult rat brain and liver, females were
injected with increasing dosages of morphine or metha-
done, or same volume of vehicle (saline) for two
weeks. The final dosages of opiates (morphine 40 mg/Kg,
i.p. and methadone 10.mg/Kg, i.p.) were maintained
for 9 days before decapitation..
2.2.2 Preparation of Samnles
Rats, newborns or adults of both sexes, were
sacrified by decapitation 30 minutes after the last
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injection. The brains were rapidly removed and dis-
sected into whole forebrain, brain stem and cerebellum.
Small pieces of liver from each lobe were removed.
Each tissue was homogenized in 0.25 M sucrose, using
a Thomas tissue grinder (type B). The homogenates
of each brain regions were diluted to 30 mg per ml
for spectrophotometric analysis and 10-20 mg per ml
for radioassay whereas liver homogenates were diluted
to 10 mg per ml for both analyses.
2.2.3 Assays of MAO Activi t Pa
MAO activities were determined by spectrophoto-
metric analysis or radioassays.
Radioassays were performed according to the method
of Wurtman and Axelrod (1963) with minor modifications,
where tryptamine-i4C and dopamine-3H were used to
assay total MAO activity, while 5-HT-14C was used
to assay type A MAO activity. The final concentrations
and specific activities of the substrates were: try-
ptamine (1.7 x 10- 4 M), 1.92 mCi/mmol dopamine (0.66 mM),
11 mCi/mmol and 5-HT (5.1 x 10-4 M), 0.66 mCi/mmol
Incubation was carried out at 37°C for 20 minutes and
started by adding 100/441 homogenate. Each incubation
tube, besides tissue homogenates, contains 100,l
substrates (50 1, when dopamine-3H was used) and
100- l phosphate buffer (0,5 M, pH 7.4). Equivalent
volume of 2 N HC1 was added to the blank at zero time.
The reaction was stopped by adding 0.2 ml of 2 N HCl.
To extract the deaminated products, 6 ml of organic
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solvent were used: toluene for tryptamine metabolites
toluene:tetrahydrofuran (2:1 v/v) for dopamine meta-
bolites and toluene:eth yl acetate (1:1 v/v) for
5-HT metabolites. The mixtures were mixed vigorously
for 15 sec and centrifuged at 1500 rpm for 5 min.
3 ml supernatant were transferred into counting vials,
and 7 ml scintillation cocktail (1 vol. Triton X-100
2 vol. toluene, 0.4% PPO and 0.04% POPOP) were added.
Radioactivities were determined by liquid-scintill-
ation spectrometry (Beckman, Model LS-330) at counting
efficiencies of 52% and 33% for 14C and 3H, respectively.
Type B MAO activity was determined by spectro-
photometric assay according to the modified procedure
of McEwen and Cohen (1963). The incubation mixture
contains 0.6 ml homogenate, 0.75 ml phosphate buffer
(0.2 M, pH 7.2), and 0.15 ml benzylamine (8 mN in
the same buffer). The blank was identical, except
that the substrate was not added until the end of
the incubation. The reaction mixture was incubated
at 37 C for 2 hrs in air'with continuous shaking.
To terminate the reaction, 0.15 ml of 60% erchloric
acid was added and followed by 1.5 ml cyclohexane.
The contents were mixed vigorously for 10 sec with
a mixer, and allowed to stand at room temperature
for 15 min. After a second mixing, the mixtures were
contrifuged at 2000 rpm for 10 min. The absorbance
of the cyclohexane extract from each experimental
tube was measured using a UV-Vis spectrophotometer
20
(Hitachi, Model 139) at 242 nm against that of the
blank extract.
2.2.4 Protein Determination
Protein determination was performed by a modific-
ation of the Lowry procedure as suggested by Markwell
et al., (1978). The addition of sodium dodecyl sulfate
in the alkaline reagent and an increase in the amount
of copper- tartate reagent allowed the method to be
used with membrane and lipoprotein preparation without
prior solubilization or lipid extraction. Besides,
the influence of sucrose or EDTA on protein determin-
ation was also eliminated.
2.2.5 Data Analysis
Data were analysed by the Student's "t" test
(Campbell, 1974).
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CHAPTER III BIOCHEMICAL STUDIES OF MULTIPLE FORMS
OF MAO IN RAT BRAIN AND LIVER
3.1 Introducti
Many mammalian tissues contain two forms of MAO activity,
A and B, that differ in their substrate specificities and
sensitivities to inhibitors. Studies of the enzyme from
rat brain and liver showed that tyramine , tryptamine
dopamine and kynuramine are common substrates for both
forms of this enzyme (Hall et al., 1969 Houslay and Tipton,
1974 Mantle et al., 1975 Squires, 1972) adrenaline
(Houslay et al., 1974), noradrenaline
(Goridis and Neff,
1971 Houslay et al., 1974) and serotonin
(Johnston, 196$)
are preferred substrates for type A enzyme which is sensitive
to clorgyline (Johnston, 1968) benzylamine
(Hall et al.,
1969) and B-phenylethylamine (Yang
and Neff, 1973) appear
to be preferred substrates for type B enzyme
which is
sensitive to deprenyl (Knoll et al., 1965 Knoll and Magyar,
1972). Thus, inhibition of the activity towards common
substrate by clorgyline or deprenyl has been
used to assess
the relative proportions of the two enzyme types present.
These studies were sometimes supplemented by studies using
a type A substrate and a type B substrate. Studies using
substrate specificity and inhibitor sensitivity showed
that the apparent proportions of these two forms of MAO
vary widely between various organs in rats (Tipton
et al.,
1976), and between different animal species (Hall et al.,
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1969 Squires. 1972
Recently, several reports revealed that the binary
classification into type A and type h MAO with defined
specificities may be over-simplified. For example, studies
with clorgyline as the inhibitor have shown that in rat
heart homogenates benzylamine is
a substrate for both forms
of the enzyme whereas tyramine is a
substrate for type A
enzyme only (Lyles and Callingham, 1974),
while in the
beef heart, serotonin is a substrate for both types of
MAO (Mantle et al., 1976). A biphasic inhibition curve
(an indication of a common substrate) has also been observed
for the oxidation of
: -phenyl e thylamine, a B type substrate,
using mouse brain enzyme preparation
(Harmer, 1976). In
addition, other factors, such as substrate types, pr-eincu-
bation time, enzyme concentration
inhibitor concentration,
and enzyme inhibitor ratios employed in the assay all
influence the resultant time-course and the final degree
of inhibition observed (Aches and Gabay, 1977b Lyles and
Greenawalt, 1977, 1978). Thus$ these factors should be
fully investigated when using inhibitors
to indicate the
presence of multiple forms of MAO.
In order to investigate the Possible physiological
roles of different forms of MAO, the
distribution, micro-
environment, and nature of binding site(s) of these two
enzymes in different brain regions were studied. The liver
enzyme was also included to serve as a comparison.
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3.2 Inhibitor Sensitivities and Substrate Specificities
Since O.
0.5 M of clorgyline and deprenyl were low
enough to inhibit selectively MAO A and MAO B respectively
(Jourdikian et al., 1975), this concentration was chosen
to study the inhibitor sensitivity and substrate specificity
of rat brain and liver MAO.
Table 3.1 showed that in all brain regions and in the
liver, tryptamine and dopamine were common substrates
for both types of MAO, while serotonin and bentYlamine were
specific substrates for MAO A and MAO B, respectively.
These findings were consistent with those of Johnston
(1968) and Hall et al. (1969) observed with whole rat brain
and rat.liver homogenates. Since clorgyline, but not
deprenyl, inhibited the oxidation of 5-HT completely and
deprenyl, but not clorgyline, abolished the oxidation of
benzylamine, these results suggest that these two inhibitors
are specific.
The result also showed that the ratios of MAO A activity'
MAO B activity (A/B) were not the same in all brain regions
and in the liver, being at least 50/ higher in all brain
regions studied. This finding may indicate different micro-
environment and/or characteristics of MAO in different
tissues and brain regions. Also, this observation suggests
that more type A enzyme is present in the brain than in
the liver, which may very well be related to the brain
function since monoamine neurotransmitters in the brain
can be degraded efficiently by MAO A.
Moreover, differences were found between A/B ratios
24
Table 3.1 Substrate s ecificities and inhibitor sensitivities of MAO in rat
brain and liver.
Homogenates of rat brain and liver were preincubated with 0.5uM
clorgyline or deprenyl at 0°C for 35 min, and the enzyme assays
were carried out as described in the text
Substrate
Region MAO Activity
No Inhibitor Clorgyline Deprenyl A/B



















































































MAO Activity is expressed as
nmoles substrate oxidized/mg protein/min for
tryptamine, dopamine and 5-HT, and 4A 242/mg protein/hr
for benzylamine.
A/B was calculated by io Total A/% Total B
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determined with trypAa mine and dopamine in each structure
studied, which indicates the different binding affinities
of the two types of MAO for different cornrnon substrates.
3-3 Thermal Denaturation Studies
Thermal denaturation studies have been used as one
of the techniques to demonstrate the existerice of multiple
forms of MAO. Youdim and Sourkes (1965) have reported a
non-homogeneous thermal inactivation of MAO in rat liver
mitochondria using kynuramine as substrate, and Lyles and
Greenawalt (1978) have recently demonstrated that pig
heart MAO also contained a therniolabile component and a
thermostable component. Whether the MAO in different brain
regions also contain these two components is unknown.
In this study, the effect of thermal denaturation
on MAO activity in the whole forebrain, brain stem, cere-
bellum and liver of rat were examined to obtain information
about the distribution and characteristics of multiple
forms of MAO in these structures. Tryptamine, a common
substrate, 5-HT, a type A substrate, and benzylamine, a
type B substrate, were used in this study.
Data for the thermal inactivation of MAO activity
were shown in Figs. 3.1-3.3. The inactivation curves were
annnlysed into two linear components by "backward projection"
method used by Jarrott (1971). Briefly, whenever a slow
and a fast inactivated linear component can be distinguished
the backward projection th d subtravtion of this slowly
inactivated component from the initial region of the curve
yields points which give a linear, rapidly inactivated
enzyme component for each substrate. The proportions of these two
27
Fig. 3.1 Time course of heat inactivation at 55°C
of MAO activity towards tryptamine in
whole forebrain (a), brain stem (b),
cerebellum (c) and liver (d). Experimental
data were represented by (●) and were the
means of duplicate determinations. The
rapidly inactivated enzyme components
resolved from the experimental curve by
the backward projection method, as described
















































Fig- 3.2 Time course of heat inactivation at 55°C
of MAO activity towards 5-HT in whole
forebrain (a), brain stem (b),
cerebellum (c) and liver (d). Experimental
data were represented by () and were the
means of duplicate determinations. The
rapidly inactivated enzyme components
resolved from the experimental curve by
the backward projection method, as described


















































Fig. 3.3 Time course of heat inactivation at 55°C
of MAO activity towards benzylamine in
whole forebrain (a), brain stem (b),
cerebellum (c) and liver (d). Experimental
data were represented by (0) and were the
means of duplicate determinations. The
rapidly inactivated enzyme components
resolved from the experimental curve by
the backward projection method, as described


















































Table 3.2 Relative proportions and half-lives (T1/2) for inactivation of linear
























-- cannot be determined
Substrate
Thermolabile Component Thermosstable Component
T/2(min)
Proportion(%) T/2(min)





















enzyme components 'and the half-lives ('ph) for their in-
activation as determined by this method were shown in
Table 3.2.
Generally, there were a major thermolabile component
and a minor therrnostable component in each substrate-metabolizing
activity of MAO in all structures studied, except that
in the cerebellunt and liver where more than two components
were observed when using tryptamine as the substrate.
In these cases, backward projection method could not be
used and therefore cannot be resolved into a fast and
a slow inactivation component. Moreover, in these two
structures, the thermolabile component was 100% when benzyl-
amine was used as substrate.
A consistently greater proportion of thermolabile
component for benzylamine than for tryptamine or 5-HT
metabolism was observed in all the structures studied
(Table 3.2). Moreover, the half-lives (T/) of the two
components for 5-HT (a type A substrate) were much larger
tha:Z those for benzylamine (a type B substrate) in all'-:
the brain regions studied. These findings may indicate
that type A MAO is more thermostable than type B MAO in
these structures, and this finding is in agreement with
those of Squires (1968) and Yang et al. (1972) observed
in whole brain and ganglion homogenates.
Furthermore, the MAO activity in the brain stem was
found to be more heat stable than those in other brain
regions studied as the percentages of thermostable components
were largest for all the substrate-metabolizing activitipR
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studied (Table 3.2).
The heat denaturation characteristics of MAO in the
cerebellum and liver were quite similar: the inactivation
curves for tryptamine in these two structures were very
similar, but they were different from those of the whole
forebrain and brain stem and the percentages of the thermo-
labile components for 5-HT and benzylamine were almost the
same but were greater than those in the whole forebrain
and brain stem.
3.4 Kinetic Studies
Since kinetic studies are useful for investigating
the nature of binding site(s) of an enzyme, studies were
performed with the whole forebrain.
In order to investigate whether the presence of.a
selective inhibitor will alter just one type or both types
of MAO, 0.5 M clorgyline or 0.5 M deprenyl were used to
selectively inhibit type A and type B MAO respectively.
In the presence of clorgyline, a selective type A enzyme
inhibitor, the Vmax and Km values determined by ben zylamine,
a type B substrate, did not change significantly (Fig. 3.4).
Similarly, deprenyl, a specific type B enzyme inhibitor,
failed to alter the kinetic parameters when 5-HT, a type A
substrate, was used (Fig. 3.5). These findings suggest
that 5-HT and benzylamine are specific substrates for type
A and type B MAO respectively, and that the binding of one
specific inhibitor on the enzyme does not alter the kinetic
properties of the other type of MAO
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Fig- 3.4 Lineweaver-Burk plot of the uninhibited
() and the clorgylirie-inhibited (0)
enzymes in the whole forebrain of rat
towards benzylamine.
The clorgyline-inhibited enzyme was
preincubated with 0.5 RM clorgyline at
0















Fig- 3.5 Lineweaver-Burk plot of the uninhibited
(0) and the deprellyl-inhibited (0)
enzymes in the whole forebrain of rat
towards 5-11T.
The depreliyl-:inhibited enzyme was
preincubated with 0.5 . IN1 deprenyl at 0°C
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40
When tryptamine, a common substrate, was used to
determine the kinetic parameters in the presence of deprenprenyl
or clorgyline (Fig. 3.6), it was observed that the Vmax
of the uninhibited sample (1.282 nmoles/mg protein/min)
was nearly equal to the sum of the values of the clorgyline-
prenylinhibited (0.50 nmoles/mg protein/min) and the de ren
inhibited (0.80 nmoles/mg protein/min) samples whereas
samples the Km value of the uninhibited sample (0.25 x 10-4M)
was found to be in between those of the clorgyline-treated
(0.71 x 10-4M) and deprenyl-treated (0.15 x 10-4M) samples.
These findings indicate that the uninhibited Vmax and Km
values are resultants of the contributions of the two
independent binding sites of the enzyme. The results were
similar to those of Ekstedt (1976) observed in rat liver
mitochondria.
The results of the kinetic studies were summarized
in Table 3.3.
3.5 Discussion
The inhibitor sensitivities and kinetic studies
support that tryptamine and dopamine are common substrates,
5-HT is a type A substrate and benzylamine is a type B
substrate for MAO in the whole forebrain, brain stem
cerebellum and liver of rat.
However, differences were found between the A/B ratios
determined with tryptamine and dopamine in each structure
studied, indicating the different binding affinities of the
two types of MAO for different common substrates, which
41
Fig. 3.6 Lineweaver-Burk plot of the uninhibited
(0), the clorgyline-inhibited (0) and-
the deprenyl-inhibited (*) enzymes in
the whole forebrain of rat towards
tryptarnirie.
The clorgyline- and the deprenyl- inhibited
enzymes were preincubated with 0.5 M
inhibitor at 0°C for 35 min. Each point
is the mean of triplicate determinations.
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Table 3.3 Km and Vmax values of the uninhibited, the cloy line-inhibited




+Clorgyline +Deprenyl Control +Clorgyline +Deprenyl
Tryptamine 0.025 0.071 0.015 1.282 0.500 0.800
5-HT 0.500 0.500 3.509 3.571
Benzylamine 0.270 0.280 0.276 0.276
Vmax for tryptamine and 5-HT is nmoles/mg protein/min,
that for benzylamine is A242/mg protein/hr.
cannot be determined.
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may thus explain the relative proportions of the two enzyme
types assessed by the inhibition of activity with selective
inhibitors towards different common substrates may vary.
The kinetics of thermal inactivated samples indicates
the presence of a thermolabile and a thermoltable components
for each substrate-metabolizing activity. Moreover, some
substrate-dependent differences and tissue as well as regional
specificities in the relative proportions of these components
were found. These results suggest the possible heterogeneity
of MAO in the liver, and in various brain regions. The
nature of this heterogeneity is unclear.
In view of the finding of Oreland and Eksted (1972)
who demonstrated that the addition of lipid to purified
pig liver MAO results in considerable increase in thermal
stability, it is conceivable that the type A MAO is more
thermostable than type B MAO (Table 3.2) and that the substrate-
binding region for type A substrate (5-HT) may be better
protected by lipid than that for type B substrate (benzyl-
amine).
The difference in the A/B ratio and the difference
in thermostability among the structures studied may indicate
different lipid environments of the enzyme in these structures.
The results of the kinetic studies showed that the
binding of a selective inhibitor of one form of MAO did
not alter the kinetic parameters of the other. This obser-
vation suggests that these two inhibitors are very specific.
Moreover, the Vmax of the uninhibited sample was found to
be nearly equal to the sum of the clorgyline-inhibited
35
and the deprenyl-inhibited sample, whereas the Km value
of the uninhibited sample was in between those of the two
inhibitor-treated samples when a common substrate was
used to determine the kinetic parameters in the presence
of clorgyline or deprenyl. These findings indicate that
there may be at least two independent binding sites for
MAO substrates. Type A substrates bind to one site and type B
substrates bind to the other while common substrates may
bind to both sites and that the apparent Vmax and Km values
observed with common substrates are contributed by these
two independent binding sites on the enzyme.
One interesting observation is that the Km value of
type A MAO obtained with the deprenyl-treated enzyme for
tryptamine, a common substrate, was much smaller than that
obtained with the uninhibited enzyme for 5-HT, a specific
type A substrate. Base on the two binding sites proposal
for MAO by Knoll (1978b) which states that MAO A should
have the lowest Km for 5-HHT, the present finding appears
to support the proposal of White and Wu (1975) which states
that there may be more than two binding sites on MAO mole-
cule(s) for monoamines.
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CHAPTER IV ONTOGENIC STUDY OF MULTIPLE FORMS OF
MAO IN RAT BRAIN AND LIVER
4.1 Introduction
A great deal of evidence favors the view that brain
noradrenaline and 5-HT modulate primitive patterns of
behavior (Brodie et al., 1959), and investigation of the
levels of monoamines in the brain during development has
been used as another approach to further elucidate
the physiological significance of these amines in normal
and pathophysiologicai conditions (Karki et al., 1962
Mabry and Campbell, 1977). MAO, which plays an important
role in regulating the presynaptic concentration of tnono-
amines (Tipton, 1973), has also been studied at various
age of development (Gripois, 1975). However, differences
exist between the results of different workers due to different
experimental conditions used. Moreover, only few workers
had paid attention to the development of multiple forms
of MAO which may play a role in fine regulation of mono-
amines in the brain. In addition to this, the development
of multiple forms of MAO in different tissues and various
brain regions have not been well studied. Therefore,
the ontogenic development of multiple forms of MAO in
different brain regions and liver of rats was investigated.
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4.2 Development of Total MAO Activity in Rat Brain and
Liver
When the common substrate, tryptamine, was used to
determine the total MAO activity (Fig. 4.1), it was observed
that the activity in the whole forebrain rose rapidly from
day 2 after birth, reached the adult level at about day
21 postpartum (p.p.), and then leveled off. The MAO activity
at day 2 p.p. was about 30% of the adult level. In the
brain stem, the activity also increased rapidly in the
first week, followed by a gradual increase which leveled
off from day 21 p.p. At day 2 p.p. the activity was about
50% that of the adult in this region. The developmental
pattern of MAO activity in the cerebellum was quite different
where the activity increased slowly in the first week and
remained at the same level in the second week, which was
followed by a rapid increase from day 14 p.p. and then
slowed down again at day 35 P.P. The MAO activity in
this region of the newborn was also about 30% of the adult
level,
In the liver, which is a non-neuronal tissue, the
MAO activity was about twice that of the brain regions
at all the ages studied. The MAO activity of the newborn
was about 40% that of the adult, and reached the adult
level at about the fifth week. On the whole, the changes
of activity in the liver was most rapid in the first two
weeks after birth.
When dopamine, another common substrate, was used
to investigate the development of MAO activity (Fig. 4.2)
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Fig- 4.1 Ontogenic development of total MAO
activity in rat brain and liver.
Total MAO activities in the whole
forebrain (●), brain stem(0), cerebellum
(●) and liver(0) of rats were determined
with tryptamine as described in the text.
Each point is the mean + S.D. of






















Fig. 4.2 Ontogenic development of total MAO
activity in rat brain and liver.
Total MAO activities in the whole
forebrain(), brain stem (),cerebellum
(●) and liver (●) of rats were determined
with dopamine as described in the text.
Each point is the mean + S.U. of





















the developmental patterns in different brain regions were
similar to those obtained with tryptamine as the substrate.
Compared with the results obtained with tryptamine as the
substrate, higher percentage of the adult MAO activity
was observed in the newborn when dopamine was used as the
substrate the values being 30%, 50%, and 30% in the whole
forebrain, brain stem and cerebellum respectively with
tryptamine, and 40%, 70% and 40% with dopamine in corres-
ponding regions. The pattern of MAO activity in the liver
during development was different from that determined with
tryptamine, where a sudden rise in enzyme activity in the
third week was observed. The discrepancies observed with
these two common substrates may be due to the differences
in the affinities of the enzyme for these substrates as
observed with the adult enzyme (see Chapter III).
4.3 Development of Type A MAO Activit in Rat Brain and
Liver
When 5-HT-14C was used as the substrate to measure
the activity of MAO A during development (Fig. 4.3) the
patterns observed in the structures studied were quite
different from those determined with common substrates
(Figs. 4.1 and 4.2).
The MAO activity in the whole forebrain increased
rapidly after biro and peaked at about day 21 p.p. then
the activity dropped to the adult level and remained unchanged.
The newborn MAO A levt was about 50/ of the adult level
which was reached at da- 14 p.p.
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Fig. 4.3 Ontogenic development of MAO A activity
in rat brain and liver.
MAO A activities in the whole forebrain
brain stem cerebellum
and liver
of rats were determinpa
with 5-HT as described in the text-
Each point is the mean S.D. of





































In the brain stem, the MAO A level of the newborn
was equal to that of the adult. The enzymic activity rose
slightly after birth and remained almost constant in the
following two weeks it then decreased gradually to the
adult level.
In the cerebellum, a plateau was observed in the
second week and then the activities increased rapidly
and peaked at the fifth week. The newborn MAO activity
was about 60% of the adult level which was reached at day
21 p.p.
The enzymic activity in the liver increased rapidly
after birth and peaked at day 21 p.p. It then dropped
slightly and remained at a level similar to that of the
adult. The newborn MAO activity was about 4O% that of the
adult.
4,4 Development of Type B MAO Activit in Rat Brain and
Liver
Benzylamine was used to measure specifically MAO B
activity, the patterns were depicted in Fig. 4.4.
The most prominent phenomenon observed in the whole
forebrain was the drastic elevation of activity after
birth. The activity increased by 5-fold from day 2 p.p.
to day 21 p.p., and remained at that level throughout the
second month. Similar pattern was observed in the brain
stem, but the elevation of activity after birth was less
steep, where a 4-fold increase was observed from day 2 p.p.
to day 21 p.p.
In the cerebellum, the activity increased rapidly
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Fig. 4.4 Ontogenic development of MAO B activity
in rat brain and liver.
MAO B activities in whole forebrain
brain stem cerebellum
and liver
of rats were determined with
benzylamine as described in the text.
Each point is the mean S.U. of
















in the first 4 weeks and then the rate gradually slowed
down, but the activity was still increasing throughout
the second month. The newborn MAO activity was about 20%
of the adult level.
The activity in the liver did not increase as rapid
as those in the brain regions, in this tissue the activity
leveled off at day 14 p.p. The newborn MAO activity was
already 60% of that of the adult.
4.5 Developmental Patterns of MAO Activity Determined
with Selective Inhibitors
To ascertain the developmental patterns of type A
and type B MAO activities determined with preferred sub-
strates, as described in Section 4.3 and 4.4, clorgyline
and deprenyl (0.5/1M) were used to selectively inhibit
MAO A and MAO B activities respectively, with tryptamine
as the substrate.
Fig. 4.5 shows the deprenyl inhibition (MAO A activity)
curves in the liver and various rat brain regions. Compared
with the MAO A activity in the corresponding structures
determined with 5-HT (Fig. 4.3), the results in the whole
forebrain were very similar, and that the pattern in the
brain stem was also similar to that determined with 5-HT
except that the newborn MAO A activity determined with
tryptamine in the presence of deprenyl was only 70% of the
adult level, while the 5-HT-metabolizing activity in the
newborn was already 100% of the adult. In the cerebellum,
the pattern observed in the presence of deprenyl differed
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Fig. 4.5 Deprenyl inhibition curves towards
tryptamine-metabolizing activity in
rat brain and liver.
MAO activities in the whole forebrain
brain stern cerebellum
and liver of rats were determined
with tryptamine after preincubation with
deprenyl at for 35 min.
Each point is the mean S. D. of





















from that observed with 5-HT where the activity seemed to
increase gradually throughout the first two months in the
former while a decrease in activity was observed from day
28 p.p, onwards in the latter. The MAO A in the liver
of the developing rat determined with tryptamine in the
presence of deprenyl peaked at day 35 p,p, instead of day
21 P. P. with 5-HT, and that in the former determination
the adult level was reached one week later than the latter
Fig. 4.6 showed the clorgyline inhibition (MAO B act-
ivity) curves in rat brain regions and in the liver.
Comparing these curves with those determined with th benzyl-
amine (Fig. 4.4), it was observed that in the whole forebrain
and brian stem, the activity determined in the presence
of type A inhibitor increased at a less rapid rate in the
first 21 days after birth moreover, the adult level was
not reached until day 35 P.P. in both regions. The pattern
in the cerebellum was consistent with that determined with
benzylamine.
The activity in the liver did not reach adult level
at day 14 p.p., but tended to increase until day 35 P.P.
Thus at day 2 p.p. the MAO activity was only about 40%
of the adult level.
4.6 Changes in A/B Ratio During Development
The ratio of type A MAO activity: type B MAO activity
(A/B) was determined by selective inhibition with clorgyline
and deprenyl, using tryptamine as the substrate, The act-
itity remaining in the presence of depreny1 was taken as
the activity of MAO A and that in the presence of clorgyline
62
Fig. 4.6 Clorgyline inhibition curves towards
tryptamine-metabolizing activity in
rat brain and liver
MAO activities in the whole forebrain
brain stem cerebellum
and liver
of rats were determined with
tryptamine after preincubation with
clorgyline (0.5 aM) at 0°C for 35 min.
Each point is the mean + S.D. of





















was taken as the activity of r1AO B. The changes in A/B
ratio in rat brain and liver during development was depicted
in Fiz. 4.7
The most prominent phenomenon observed was that the
A/B ratios in various brain regions of newborn rat were
much higher than that in the liver, the ratios in the
whole forebrain, brain stem, cerebellum and liver were
about 6.5, 9.5, 5.5 and 1.0 respectively, This result
indicate that MAO A develops much earlier than MAO B in
the brain and may reflect that MAO A is more important
than MAO B in the rat brain in the neonatal life, this
view is in line with the belief that MAO A plays a more
important role in regulating monoamine neurotransmitter
concentrations in neuronal tissues (Tipton, 1973)- The
equal proportion of MAO A and MAO B in the liver of new-
born may suggest that both types are of equal importance
in the liver.
The A/B ratios in the three brain regions decreased
after day 2 p.p. and leveled off at day 28 p.p. On the
other hand, the ratios in the liver maintained nearly at
the same level throughout the postnatal life. The A/B
ratios, at day 60 p.p., in the whole forebrain, brain stem
cerebellum and liver were about 2.5, 2.5, 1.7 and 1.2
respectively. The decrease in A/B ratio, which was accom-
panied by an increase in MAO B, in the brain regions may
suggest that as the animal matures the deamination of amines
other than those neurotransmitter amines becomes increasingly
important in the brain. MAO B is mainly responsible for
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Fig. 4.7 Changes in A/B ratio in rat brain and
liver during development.
The A/B ratios in the whole forebrain
brain stem cerebellum
and liver
of rats were calculated
from the corresponding values in Figs
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the deamination of non-neurotansmitter amines.
It is of interest that the A/B ratio in the whole
forebrain and brain stem changed in a similar manner from
day 14 p.p. onwards, and that the changes in the cerebellum
and liver were parallel. The findings that the A /B ratios
are different in the structures studied suggest that the
distribution of these two types of MAO are regional specific
and that such specificities are already prominent at the
early age.
4.7 Kinetic Studies of MAO Activit in Developing Rat
Brain and Liver
In order to obtain more information on the character-
istics of the MAO in rat brain during development kinetic
analyses were performed, using tryptamine and 5-HT as the
substrates. The data were depicted in Figs. 4.$ and 4.9
and the Km and Vmax values were tabulated in Table 4.1
and 4.2.
The Km values for tryptamine (Table 4.1) in the whole
forebrain and brain stem were 11.8 M in both regions
day 7 p.p. and 16.7 M at days 21 and 35 p.p. However,
the Km in the brain stem at day 14 p.p. was higher than
that in the whole forebrain.
In the cerebellum, the Km for tryptamine was only
9.4 4M at day 7 P.P. which was smaller than those in the
whole forebrain and brain stem. The value in the cerebellum
increased gradually throughout the first month and reached
21.3 M which was larger than those in the whole forebrain
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Fig. 4.8 Lineweaver-Burk plots of MAO activity
towards tryptamine in the brain and liver
of rats of various aes.
MAO activities in the whole forebrain
brain stem cerebellum
and liver
of rats of various ages were determnAd








































Fig. 4.9 Lineweaver-Burk plots of MAO activity
towards 5-HT in the brain and liver of
rats of various ages.
MAO activities in the whole forebrain
brain stem cerebellum
and liver
of rats of various ages were determined
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Table 4.1 Kinetic parameters of MAO activity towards tr tamine as estimated
from Fig. 4.8
Age Km (M)
Vmax (nmoles/mg pr./min)(day) Whole Brain Cere-
Whole Brain Cere-
forebrain stem bellum Liver
forebrain stem bellum
Liver
7 11.8 11.8 9.4 3.3 0.562 0.870 0.420 1.887
14 11.8 16.7 11.8 30.0 0.893 1.111 0.513 2.203
21 16.7 16.7 13.3 50.0 1.053 1.053 0.625 2.857
35 16.7 16.7 21.3 50.0 1.176 1.176 1.000 3.125
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Table 4.2 Kinetic parameters of MAO activit towards 5-HT as estimated
from Fig. 4.9•
Age Km (m.M) Vmax (nmoles/mg pr./min)
(day) Whole Brain Cere- Whole Brain Cere-
forebrain stem bellum Liver Liver
forebrain stem bellum
7 1.00 0.33 1.00 0.40 3.030 2.500 2.703 3.704
14 0.20 0.20 0.15 0.15 2.326 2.632 1.o64 3.704
21 0.20 0.20 0.20 0.20 2.381 2.703 1.613 3.846
35 0.20 0.20 0.20 0.20 1.613 2.083 2.083 5.000
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and brain stem. The Km for tryptamine in the liver at day
7 P.P. is larger than those of the brain regions in animal
of the same age, it then increased and maintained at the
same level (50RM) from day 14 p.p. onwards-
On the other hand, the changes in Vmax paralleled
the developmental pattern of MAO activity of the corresponding
regions (Fig. 4.1)
Since the increases in Vmax values in all the regions
studied were accompanied by a slight increase or no change
in Km values, these may indicate an increase in the number
of functional enzyme molecule for tryptamine before day
21 p.p. in the whole forebrain, before day 14 p.p. in the
brain stem, and throughout the first month in the cerebellum
and liver.
When 5-UT was used as substrate (Table 4.2), the
Km values were found to be 0.20 mM at day 35 P.P. in all
the regions studied, however, the changes from day 7 p.p.
were not the same.
In the whole forebrain and brain stem, the Km values
decreased at day 7 p.p. and maintained the same from day
14 p.p. onwards, but higher in the whole forebrain at day
7 p.p.
The changes in Km values in the cerebellum and liver
during the first month after birth were similar (Table 4.2).
In both structures, the Km values decreased at day 7 p.p.
and then rose again at day 14 p.p. and reached the adult
value at day 21 p.p., but the Km value in the cerebellum
was much higher than that in the liver at day 7 p.p.
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In the whole forebrain, the Vmax decreased rapidly
in the second week and remained at the same level in the
third week, followed by a further decrease at day 21 p.p.
In the brain stem, the Vmax increased slightly in the second
week then maintained at the same level in the third week
which was followed by a decrease at day 21 p.p. In the
cerebellum, the Vmax decreased at day 7 p.p. and then in-
creased from day 14 p.p. onwards. Similar changes in
Vmax values were observed in the liver during development.
The changes in Vmax observed in these structure during
development may be due to a decrease or an increase in
the number of functional MAO A.
Lastly, from the Vmax values obtained with 5-HT as
the substrate, it was found that the changes in Vmax values
during development matched fairly well with the develop-
mental pattern of MAO A activity as shown in Fig. 4.2.
4.8 Discussion
The developmental patterns of type A, type B, and
total MAO activity in rat brain observed in the present
study were in general closely related to the level of mono-
amines in the brain during the first month after birth
'(Bourgoin et al., 1977 INlabry and Campbell, 1977 Porcher
and Heller, 1972), whenever the MAO activity was high, the
corresponding monoamine concentrations in the brain were
low. This is not surprising since MAO is the main degrad-
ative enzyme of brain monoamines and that MAO is believed
to play a regulatory role in monoamine neurotransmitter
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biosynthesis (see Chapter I)
It has been reported that the noradrenergic and sero-
tonergic neurotransmission systems followed a caudal to
rostral sequence of development (Pscheidt and Himwich,
1966 Lanier et al., 1976). In this study, the caudal to
rostral sequence of development of MAO was observed with
all substrates studied the percentage of adult MAO activity
in the brain stem of newborn rat was greater than those
in the whole forebrain moreover, the age at which the adult
level was reached in the brain stem was in general earlier
than that in the whole forebrain (Table 4.3). Furthermore,
the changes in Km values determined with tryptamine (Table 4 .1)
or 5-HT (Table 4.2) also followed a caudal to rostral,se uequence
This is not surprising in view of the fact that MAO is
the metabolizing enzyme of these neurotransmitter mono-
amines. The similar time course and developmental sequence
of these two systems may suggest that the biosynthesis
of monoaminergic neurotransmitters in the brain is already
under control.
Differences were observed in the developmental patterns
of multiple forms of MAO activity, i.e. total MAO activity
(determined with tryptamine or dopamine), MAO A activity
(determined with 5-HT or deprenyl inhibition towards tryp-
tamin.e) and MAO B activity (determined with bentYlamine
or clorgyline inhibition towards tryptamine) in rat brain
regions and liver. In general, the developmental patterns
of the total MAO activity can be interpreted by the com-
plementary changes in MAO A and MAO B activities during
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Table 4.3 Chan es of multi le forms of MAO activlt
in rat brain and liver durin development.






























5-HT Brain stem 100 (70) 2 7)
Cerebellum








Brain stem 20 (20)
21 (35)




The values in the parentheses were determined
with selective inhibitors, clorgyline or
deprenyl, using tryptamine as the substrate.
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development, i.e. the developmental curve of total MAO
activity measured with tryptamine or dopamine was between
those obtained with 5-HT or deprenyl inhibition towards
tryptamine and benzylamine or clorgyline inhibition towards
tryptamine. These results were in agreement with those
of Bourgoin et al. (1977). These workers used kynuramine,
benzylamine and [3H] 5-HT to measure the MAO activities
in the whole forebrain and brain stem of developing rats.
However, in the developing whole forebrain and brain stem,
MAO A activity reported by these authors was generally
much lower then that of the present study. This discrepancy
may be due to the much lower [3H]5-HT concentration used
in their experiments and/or differences in the assay conditions.
As shown in Table 4.3, although the developmental
patterns of total MAO activity determined with tryptamine
and dopamine were similar, but the dopamine-metabolizing
activity in the newborn brain was higher than the trypt-
amine-metabolizing activity. Also, variations in the age
of maturation of type A and type B MAO activity were observed
when these activities were determined by using selective
inhibitors (clorgyline or deprenyl) and with specific sub-
strates (5-HT or benzylamine). These variation may be
due to the differences in the affinities of these two
enzymes for the substrates used.
The higher proportion of type A to type B MAO observed
in the brain regions during the first month after birth
and throughout postnatal life may be of physiological
importance since MAO A is the major enzyme responsible
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for the degradation of most of the monoamine neurotrans-
mitters. In the newborn, the MAO activity in the liver
is.much higher than that in the brain this is because`', in
the rat, the liver is almost fully functional at birth while
the brain is still developing after birth. Moreover, from
the kinetic studies, it was found that the number of functional
MAO molecule for tryptamine and 5-HT in the liver was greatest
in all the regions studied because of its highest Vmax
value but largest or equal Km value (Table 4.1 and 4.2)_
Although the cerebellum is a structure in the brain,
the MAO developmental pattern, the change in A/B ratio during
development, and the changes in kinetic parameters during
early postnatal life were all different from those of the
whole forebrain and brain stem however, the properties
of the MAO during development in the cerebellum and liver
were similar as for examples, the changes in A/B ratio
(Fig. 4.7) and kinetic parameters (Tables 4.1 and 4.2).
The significance of this observation is not too apparent
at present, but may be related to the lower level of mono-
amines in the cerebellum. The'monoamines in the brain are
highly concentrated in the midbrain region.
During development, the kinetic parameters (Km and
Vmax) increased in all the structures studied when using
tryptamine as the substrate while the kinetic parameters
determined with 5-I-IT did not follow the same pattern such
a deviation may be due to differences in the affinities
of the enzymes for these two substrates. Also, in view
of the-role played by mitochondrial lipid in the properties
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of MAO (Youdim et al., 1974), these inconsistencies in
kinetic parameters determined with different substrates
indicate that changes in lipid environment of the enzyme
may occur during development.
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CHAPTER V EFFECTS OF OPIATES ON MAO ACTIVITIES IN
ADULT AND DEVELOPING RAT BRAIN AND LIVER
5.1 Introduction
Much evidence indicates that the responses to the
administration of opiates are reaction of the central nervous
system, in particular the monoaminergic system in the brain
(for review see Clouet and Iwatsubo, 1975 Erickson, 1978).
Also, perinatal administration of opiates to the pregnant
animals had been shown to affect both functional and morpho-
logical development of offspring (Friedler, 1978 Tuchmann-
Duplessis, 1977 Zagon and McLaughlin, 1977, 1978). In
man, babies born to addicted mothers exhibit the so called
neonatal withdrawal symptoms' (Kolata, 1978).
Since monoamines in brain have been postulated to
play an important role in opiate addiction and tolerance
(Erickson, 1978) and that MAO is an important enzyme in
the degradation of monoamines in the brain, the effects
of opiates on the activity of multiple forms of MAO, and
the effect of antenatal exposure to opiates on the develop-
ment of MAO activity in offspring were investigated. Since
most of the conversions of opiates take place in the liver
(Ligon et al., 1968) and that large amount of MAO exists
in liver mitochondria, the effects of opiates or, liver
MAO were also investigated.
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5.2 In Vitro Effects of O iates on MAO in Rat Brain and
Liver
Table 5.1 summarized the in vitro effects of morphine
and methadone on MAO activities. Morphine at concentrations
10-7 M
10-3 M did not significantly alter the MAO activ-
ities in the whole forebrain and liver of rat. This result
was in agreement with that of Vanderwende and Spoerlein
(1979), but different from that of Bellin and Serrentino
(1974) who found that morphine (0.1 mM) increased MAO
activity when the concentration of 5-HT was smaller than
0.25 mM. The discrepancies may be due to the higher con-
centration of 5-HT used in the present study.
On the other Aand, methadone inhibited the enzyme
activities in a concentration dependent manner (Fig. 5.1).
The effects) of methadone on MAO in the whole forebrain and
liver. was similar regardless of substrates used. The
only difference was that high concentration of methadone
caused a re-bounce of benzylamine-metabolizing activity
in the whole forebrain while a further decrease was observed
in the liver.
In both regions, the benzylamine-metabolizing activity
was much more sensitive to methadone inhibition than the
5-HT-and the tryptamine-metabolizing activity.
5.3 In Vivo Effects of Short Term Administration of Opiates
on MAO Activities in Rat Brain and Liver
Since methadone but not morphine affected MAO activities
in the brain regions and liver in vitro, the effect of
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Table 5.1 Effects of opiates on multiple forms of MAO activity in vitro.
Brain and liver homogenates were preincubated with morphine
or methadone at 0°C for 35 min, and the activities were measured




Concentration whole forebrain Liver
(M)
T H B T H B
Morphine
0 100 100 100 100 100 100





97.9 99.1 104.0 96.0 101.1 104.6











10-5 83.2 92.3 62.3
77.7 93.0 68.6
l0-4






The values in the parentheses were the specific activities of MAO
determined with different substrates. The enzyme activities were
expressed as in the previous Chapter. Each value is the mean of
triplicate determinations of 1-2 rats.
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Fig. 5.1 Dose response curves of methadone on
multiple forms of MAO activity in rat
brain and liver.
Brain and liver homogenates were
preincubated with methadone at O°C





in the text. Each point is the mean











these two opiates on MAO activity in vivo was tested.
In this study, female rats of about 250 g were injected
twice daily with morphine (40 mg/Kg, i.p.) or methadone
(10 mg/Kg, i.p.) or same volume of saline for 9 days.
Both morphine--and methadone--treated rats exhibited convul-
sive muscular contraction. About 30 minutes after-the
last injection of opiate, the rats were sacrificed and the
MAO activities in the brain and liver determined. The
results were tabulated in Table 5.2.
Both morphine and methadone had no significant effect
on MAO in rat brain regions studied except that morphine
increased the 5-HT-metabolizing activity in the brain
stem. These results were similar to that of Reis et al.
(1970), but different from that of Catravas et al. (1977).
vn zne other hand, both opiates increased, though
in different magnitudes, the MAO activity in the liver
regardless of substrates used. Among the different amine-
metabolizing activities, the benzylamine-metabolizing
activity was most sensitive to opiate stimulation. Further-
more, the effect of morphine was more drastic than that
of methadone.
5.4 Effects of Antenatal Ex osure to Opiates on the Dev el•
ment of MAO Activities in Rat Brain and Liver
Since Ng (1979) had reported that antenatal exposure
to opiates affect the development of opiate and (_adrenergic
receptors in offspring, studies on the effect of antenatal
exposure to opiate on MAO development were carried out.
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laule 5.2 Short term effects of opiates on multi le forms of MAO activity
in rat brain and liver.
Rats were treated with opiates as described in the text.
The enzyme activities were expressed as described previously.
Each value is the mean+S.D. The value in the bracket is the
number of animals used.
Substrate Region MAO Activity
Control Morphine Methadone
whole
forebrain 1.016+0.064(5) 1.045+0.051(5) 1.053+0.071(4)
Tryptamine Brain stem 0.873+0.038(5) 0.839+0.044(5) 0.837+0.026(4)
Cerebellum 0.926+0.064(5) 0.923+0.057(5) 0.891+0.044(4)
Liver 2.445+0.217(5) 2.822+0.102(4)* 2.618+0.145(4)
Whole
forebrain 1.281+0.132(5) 1.320+0.135(5) 1.300+0.149(4)
5-HT Brain stem 1.027+0.017(4) 1.138+0.068(4)* 1.062+0 .122(4)
Cerebellum 1.201+0.136(5) 1.150+0.078(5) 1.246+0.043(4)
Liver 3.149+0.192(5) 3.638+0.209(4)* 3.416+0.153(4)
Whole
forebrain 0.211+0.019(4) 0.188+0.012(4) 0.204+0.023(4)Benzyl-
amine Brain stem 0.209+0.011(5) 0.193+0.012(5) 0.206+0.014(4)
Cerebellum 0.210+0.021(4) 0.189+0.013(4), 0.193+0.017(4)
Liver 0.594+0.017(4) 0.726+0.018(5)** 0.681+0.020(4)**
* p<0.02, **p<0.001 when compared with the control
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The effects of antenatal exposure to opiate on the
physical parameters such as mortality, body weights and
brain weights of newborns (day 2 p. p.) were summarized
in Table 5.3. The mortality rate of the two drug-treated
groups were significantly increased whereas the body
weight and brain weight were greatly reduced. These results
were in agreement with those reported in the literature
(Butler and Schanberg, 1975 Friedler, 1978 Slotkin et al.,
1980 Tsang and Ng, 1980 Zagon and NNIcLaughlin, 1977,1978).
The effects of antenatal exposure to methadone on
the development of MAO activities in rat brain and liver
were depicted in Figs. 5.2-5,4.
When tryptamine was used as the substrate (Fig. 5.2),
it was observed that in the whole forebrain, brain stem
and liver, there was a slight but significant increase
in enzyme activity at day 114 p.p., whereas no significant
change in enzyme activity was observed in the cerebellum.
When type A MAO was measured with 5-HT (Fig. 5. 3),
a significant decrease in MAO activity at day 21 p.p. in-
the whole forebrain was observed. However, no significant
change in enzyme activity in the braii-i stem and cerebellum
was observed. On the other hared, the change in the liver
was more prominent, the enzyme activity of the offspring
born to methadone-treated mother was much higher at day
14 p.p. and followed by a decrease.
Type B MAO (measured with berizylamine), in contrast,
was inert to the effect of perinatal administration of
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Table 5.3 Effects of antenatal exposure to opiates on physical parameters
of newborn rats (Day 2 p.p.).
Treatment Body Weight Weight of Weight of Weight of
whole Brain cere
(%) (g) forebrain stem bellum
(mg)(mg)
Control 7.5(40) 8.5+0.8(16) 234+15(11) 87.2+6.4(11) 17.1+1.0(8)
Morphine 15.8(38) 6.5+0.6(19)* 192+20(7)* 74.0+6.7(7)* 10.0+1.3(7)*
Methadone 27.1(48) 6.8+0.9(27)* 205+9(6)* 74.7+6.3(7)* 13.2+1.0(7)* 7
p<0.001 when compared with the control.
Each value is the mean+S.D.
The number in the parenthesis is the number of
animal determined.
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Fig. 5.2 Effects of antenatal exposure to methadone
on the development of total MAO activity
in rat brain and liver.
Rats were treated as described in the text.
Total MAO activity in the whole forebrain
(a), brain stem (b), cerebellum (c) and
liver (d) of offspring of the control and
drug-treated mothers was determined with
tryptamine. Each point is the mean+S.D.
of duplicate to triplicate determinations

























































Fig. 5.3 Effects of antenatal exposure to methadone
on the development of MAO A activity in
rat brain and liver.
Rats were treated as described in the text.
MAO A activity in the whole forebrain (a),
brain stem (b), cerebellum (c) and liver
(d) of offspring of the control and drug-
treated mothers was determined with 5-11T.
Each point is the rriean+S. D. of duplicate
to triplicate determinations made in 1-4




















































When the methadone-treated mothers were sacrificed
after a two-month treatment, it was found that the benzyl-
amine-metabolizing activity in the whole forebrain and
cerebellum was reduced significantly whereas that in the
liver was elevated (Table 5.4). However, the tryptamine-
and 5-HT-metabolizing activities did not show any signi-
ficant change.
The effects of antenatal exposure to morphine on the
developmental pattern of MAO activities in rat brain and*
liver were not significant (data not shown).
Another point worth mentioning was that, injection
of saline affected the developmental pattern of MAO activity.
The effect on the tryptarnine-metabolizing activity in
the structures studied was not significant except a signi-
ficant decrease in MAO activity in the liver was observed
at day 14 p.p. (Fig. 5.5). Injection of saline caused
a general decrease in the 5-HT metabolizing activity in
all the structures studied (Fig. 5.6), where the effect
was most pronounced in the brain stem and cerebellum.
In the whole forebrain and liver, injection of saline
caused significant decrease in MAO B activity throughout
the first month, but only caused a slight decrease in the
cerebellum and no effect was observed in the brain stem
(Fig. 5.7).
5.5 Discussion
Since in vitro study showed that methadone had an
inhibitory effect on MAO activities while morphine did
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Fig- 5.4 Effects of antenatal exposure to methadone
on the development of MAO B activity in
rat brain and liver.
Rats were treated as described in the text.
MAO B activity in the whole forebrain (a),
brain stern (b), cerebellum (c) and liver
(d) of offspring of the control and drug-
treated mothers was determined with
benzylarnine. Each point is the mean+S.D
of duplicate to triplicate determinations














































Table 5.4 Long term effects of methadone on multiple forms of MAO
activity in rat brain and liver.
Rats were treated as described in the text. Each value is




Control (3) Methadone (5)
Whole
forebrain 1.216+0.026 1.140+0.074










Benzylamine Brain stem 0.207+0.014 0.197+0.009
Cerebellum 0.238±0.003 0.220+0.011
Liver 0.531+0.026 0.631+0.021**




Fig. 5.5 Effects of injection of saline on the
development of total MAO activity in rat
brain and liver.
Hats were treated as described in the text.
Total MAO activity in the whole forebrain
(a), brain stem (b), cerebellum (c) and
liver (d) of offspring of the control
and 'injected' mothers was determined with
tryptamine. Each point is the mean+S.D.
of duplicate to triplicate determinations
































































fig. 5. Effects of injection of saline on the
development of IMIAO A activity in rat
brain and liver.
Rats were treated as described in the text.
MAO A activity in the whole forebrain (a),
brain stem (b), cerebellum (c) and liver
(d) of offspring of the control and 'injected
mothers was determined with 5-HT. Each point
is the mean-S.D. of duplicate to triplicate














































Fig. 5.7 Effects of injection of saline on the
development of I,-1AO B activity in rat
brain and liver.
Rats were treated as described in the text.
MAO B activity in the whole forebrain (a),
brain stem (b), cerebellum (c) and liver
(d) of offspring of the control and 'injected
mothers was determined with benzylarnine.
Each point is the mean+S.D. of duplicate to
















































not affect the enzyme activities, this observation suggests
that methadone does not affect the enzyme through inter-
action with opiate receptors or other systems mediating
opiate actions. Moreover, the sensitivity of different
substrate-metabolizing activities to the inhibition of
methadone was in the order of tryptamine-metabolizing act-
ivity< 5-HT-metabolizing activity< benzylamine-metabolizing
activity, this suggests that methadone affects these binding-
sites at varyinz decrreeR_
On the other hand, brain MAO activities in vivo was
not affected by short term administration of either opiates
except the benzylamine-metabolizing activity was decreased
by chronic methadone treatment, while both methadone and
morphine stimulated liver MAO activities in vivo.
The discrepancy between the short term and the in vitro
effect of methadone in the brain may be due to the fact
that methadone is rapidly metabolized in the body. This
may also explain the long term effect of methadone on the
benzylamine-metabolizing activity, which is most sensitive
to methadone as shown in the in vitro study. The stimulatory
action of both opiates on MAO activity in the liver observed
in the in vivo studies may possibly be an induction effect,
as the liver is the site mainly responsible for detoxication
reaction and that these opiates are degraded in the liver.
The results of the antenatal exposure to opiates
on the development of MAO activities also complement the
in vitro study where methadone but not morphine altered
the development of MAO in the offspring. However the
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effect of methadone on MAO development in the structures
studied is not very pronounced. This may be due to the
fact that methadone is rapidly metabolized in the mother's
body, thus very small amount of methadone was passed to
the offspring through the milk-
The MAO activity, especially the MAO A activity was
significantly reduced in rat brain and liver of the off-
spring born to mothers injected with saline, such a decrease
may be due to the stress effect of injection, as Reis et al.
(1970) had previously shown that injection of saline 2- 3
times daily caused a significant decrease in tyrosine
hydroxylase activity in rat caudate nucleus. Moreover,
the varying degree of influence on different MAO substrate-
metabolizing activities due to injection in different
structures may indicate different sensitivities of tissue
cells and/or different substrate-metabolizing activities
to the stress effect.
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CHAPTER VI GENERAI, CC)NT TTCTnMT
The inhibitor sensitivities and kinetic studies support
that tryptamine and dopamine are common substrates for
MAO, and 5-HT and benzylamine are specific substrates
for MAO A and MAO B respectively in the whole forebrain ,
brain stem, cerebellum and liver of rat. Moreover, clorgy-
line and deprenyl are proved to be highly specific inhi-
bitors for MAO A and MAO B respectively.
Results from the kinetic studies of inhibitors towards
tryptamine, 5-HT and benzylaniirie indicate that more than
two binding sites are localized on ANAO molecule(s). This sug-
gestion is in agreement with the data observed in the mixed
substrate studies of White and Wu (1979)-
The ontogenic development of multiple forms of MAO
activity is different in the structures studied, and a
caudal to rostral sequence of development of MAO types
in the brain was observed. This is because the caudal
region is an old structure in the phylogenetic scale.
Regardless of how the enzyme activities were assayed (by
selective inhibition towards tryptamine, or with specific
substrates) the development curve of the total MAO activity
in the structures studied is between those of the type A
and the type B enzyme. This suggests that total MAO activity
in these structures is a combination of the type A and B
MAO activity. MAO A is found to be relatively more active
in the early period in the postnatal life whereas MAO B
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is relatively more active in the later period. This may be
related to the functional role of the brain, as the develop-
mental time-tables of the monoaminergic neurotransmission
systems are closely related to the developmental time-
table of MAO.
The changes in A/B ratios and kinetic parameters during
development indicate that the changes in number of functional
MAO molecules for tryptamine, 5-HT and benzylamine are
not of the same pace. These results also indicate changes
in the micro-environment of the enzyme binding sites.
Regional differences in multiple forms of MAO in
adult rat and in offspring during development are quite
interesting. Generally, MAO A is relatively more active
in the brain than in the liver, and this is consistent
with the function of the brain as MAO A is mainly respon-
sible for the degradation of monoaminergic neurotransmitters
and that this enzyme has been postulated to play a regul-
atory role in monoaminergic neurotransmitter metabolism.
The activity of MAO is higher in the liver than in the brain,
this higher activity of MAO in the liver is due to a greater
number of functional MAO molecules in this structure.
This is also in agreement with the functional role of the
liver which serves as a major deacnination center in the
body.
Although cerebellum is a part of the brain, the char-
acteristics of MAO in this region differ much from those
of the whole forebrain and brain stem, and that the heat
inactivation properties and the changes in A/B ratio and
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kinetic parameters in the cerebellum are quite similar to
those in the liver. These findings indicate that different
structures may have different micro-environments for MAO
and that the diversity in the characteristics of MAO observed
in these structures is closely related to the functional
role of the structure.
Morphine and methadone have different effects on MAO
activities in vitro, indicating that the interaction of
these two opiates with MAO molecule are not the same.
On the other hand, both these opiates activate in vivo
the liver MAO activities significantly in the adult rat,
this may be due to an induction effect. Moreover, the
inhibitory effects of long term administration of methadone
on adult brain MAO may be due to the accumulation of methadone
in the brain.
From both the in vivo and in vitro studies, it can be
observed that 5-HT-mmetabolizing activity in adult rat is
less sensitive to opiate effects than that of the benzyl-
amine-metabolizing activity, this together with the finding
that MAO A is more heat stable than MAO B, it is concei-
vable that the micro-environnients of these two types of
MAO are not the same-
When opiates are injected antenatally to pregnant
female rats, the mortality rate of the newborn is increased
a
especially in the case of methadone injection. The body
weight and brain weight of the newborn rats are also
affected and now are significantly reduced. Although the
effects of methadone on MAO activities is not very pronounced
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there are significant changes in certain substrate-metabol-
izing activities in the structures studied. In view of
the effects of methdaone on brain and liver MAO and its
effect on the physical development of offspring, the use
of methadone as a 'safe' substitute in the narcotic
addiction rehabilitation programme should be re-evaluated.
Lastly, the inhibitory effect of injection on the
developmental patterns of NIAO activities in the brain and
liver observed in the present study suggest that the
dev' lopment of MAO in rat may be influenced by stress.
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